Immuneering Corporation (IMRX)
NASDAQ · Healthcare
Immuneering Corporation Net Income 2020–2023
Immuneering Corporation annual/quarterly net income history and growth rate from 2020 to 2023. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Immuneering Corporation net income for the quarter ending September 30, 2023 was -12.6 M, a 1.94% decrease year-over-year.
- Immuneering Corporation net income for the twelve months ending September 30, 2023 was -51.2 M, a 25.12% increase year-over-year.
- Immuneering Corporation annual net income for 2023 was -53.5 M, a 5.86% increase from 2022.
- Immuneering Corporation annual net income for 2022 was -50.5 M, a 50.63% increase from 2021.
- Immuneering Corporation annual net income for 2021 was -33.5 M, a 96.81% increase from 2020.
- Immuneering Corporation annual net income for 2020 was -17.0 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Immuneering Corporation Net Income — FAQ
Immuneering Corporation (IMRX) net income over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
What is Immuneering Corporation's net income?
Immuneering Corporation (IMRX) reported net income of -$53M for fiscal 2023.
Where can I see IMRX's net income history?
The chart and table above show Immuneering Corporation's net income by year and by quarter, including the growth rate.